We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Le produit de thérapie génique SENS-501 et la procédure chirurgicale sont bien tolérés par les deux premiers patients traités et des évolutions comportementales encourageantes sont observées...
Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within...
Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within...
Regulatory News: Sensorion (FR0012596468 – ALSEN), société pionnière de biotechnologie au stade clinique, spécialisée dans le développement de nouvelles thérapies pour restaurer, traiter et...
Sensorion to host a webconference dedicated to its retail shareholders on October 10, 2024, in French, at 6pm CET (12pm ET) Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.052 | -7.76119402985 | 0.67 | 0.69 | 0.594 | 49379 | 0.6426966 | DE |
4 | -0.006 | -0.961538461538 | 0.624 | 0.77 | 0.584 | 39560 | 0.66858539 | DE |
12 | -0.132 | -17.6 | 0.75 | 0.814 | 0.584 | 36466 | 0.69994544 | DE |
26 | -0.082 | -11.7142857143 | 0.7 | 0.97 | 0.584 | 42130 | 0.76008685 | DE |
52 | 0.1885 | 43.888242142 | 0.4295 | 1.04 | 0.406 | 64204 | 0.74991744 | DE |
156 | -1.118 | -64.400921659 | 1.736 | 2.29 | 0.26 | 79775 | 0.70727266 | DE |
260 | -0.237 | -27.7192982456 | 0.855 | 2.88 | 0.26 | 87039 | 1.1392789 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions